#Japan #healthcare #Tokyo #Order-epi® #Medipal Group

Medipal Group Enhances Order-epi® with New Features

Medipal Group, a leading Japanese pharmaceutical wholesaler, has recently expanded its web ordering system, Order-epi®, to include a new functionality that allows healthcare providers and pharmacies to directly check inventory status. This upgrade is aimed at streamlining the ordering process, which is critical for ensuring the timely and accurate supply of pharmaceuticals.

Addressing Current Challenges

In the ever-demanding healthcare sector, managing pharmaceutical inventory and ordering processes has become a significant burden for medical practitioners. Often, after submitting an order, they face the frustrating situation of being unable to procure their desired items, leading to an extensive search for alternatives—a process which hinders overall efficiency. Recognizing this pain point, Medipal Group aims to dissolve the time lag between order completion and delivery confirmation, acknowledging that the work is not truly finished until all items are secured.

Overview of New Features

The recent enhancement to Order-epi® introduces several key benefits to users:

• - Real-time Visibility of ALC Stock Levels: Users can now instantly see the stock levels at their respective Area Logistics Center (ALC) directly on the order screen, allowing for more informed decision-making.
• - Seamless Alternative Product Selection: In cases where an item is out of stock, users can quickly switch to an alternative product selection screen, making the entire process smoother and more intuitive.
• - Completion of Order Processes: The addition of these features means that the previously necessary processes of verifying delivery statuses and finding alternatives post-order are eliminated. When an order is placed, it effectively concludes the procurement process, effectively reducing stress in the workflow.

Future Prospects

With these upgrades, Medipal Group's strategy to revolutionize pharmaceutical supply chain management is firmly set in motion. This initiative marks a significant step toward the organization’s ambitious goals of integrating two critical elements: the ALC and Assist Representatives (AR). The enhanced Order-epi® system is not merely an improvement but serves as a foundational element in establishing a data-driven supply chain connecting customers and their respective ALCs.

Medipal Group envisions a future where essential medications are automatically delivered to healthcare institutions, thus enhancing patient care. Plans to implement predictive analytics using customer shipment data and an automatic ordering system (PRESUS®) are already in progress. By eliminating the difficulties associated with inventory management and ensuring consistent deliveries, Medipal Group is committed to enabling healthcare providers to focus more on improving patient services and interactions.

As Medipal Group continues to innovate, its goal remains clear: to support healthcare institutions and pharmacies in their mission to provide optimum patient care through reliable pharmaceutical supply solutions.

About Medipal Group

Medipal Holdings Corporation, based in Chuo-ku, Tokyo, leads in pharmaceutical wholesale operations. The company facilitates various segments, including medical supplies, cosmetics, and veterinary products. Established in 1923, Medipal Group's long-standing expertise highlights its commitment to advancing healthcare delivery in Japan.

For more information, visit Medipal Group.